Tat peptides inhibit neprilysin

Abigail Daily, Avindra Nath, Louis B. Hersh

Research output: Contribution to journalArticle

Abstract

Dementia associated with human immunodeficiency virus (HIV) infection occurs commonly in the aging population and amyloid depositions are noted in the brains of patients with HIV infection in younger age groups. This suggests a dysregulation of amyloid processing in the setting of HIV infection. The Tat protein of HIV has been implicated in the neuropathogenesis of HIV infection due to its neurotoxic and glial activation properties. However, Tat protein and Tat-derived peptides were recently also shown to inhibit neprilysin, the major amyloid β peptide degrading enzyme in brain, in a cell aggregate system. This effect could contribute to the observed accumulation of amyloid in the brain of HIV-infected patients. The authors report here that peptides derived from the Tat protein, but not Tat protein itself, inhibit homogeneous recombinant neprilysin. This inhibition was found to be competitive and reversible and therefore does not involve covalent bond formation. Tat peptides and Tat protein were slowly hydrolyzed by neprilysin. Thus the accumulation of Tat-derived proteolytic fragments may serve to inhibit neprilysin and increase amyloid β peptide levels.

Original languageEnglish (US)
Pages (from-to)153-160
Number of pages8
JournalJournal of NeuroVirology
Volume12
Issue number3
DOIs
StatePublished - Jun 2006

Fingerprint

Neprilysin
tat Gene Products
Amyloid
HIV
Virus Diseases
Peptides
Brain
Neuroglia
Dementia
Age Groups
Enzymes
Population

Keywords

  • Amyloid β peptide
  • Catabolism
  • Inhibition
  • Neprilysin
  • Tat-derived peptides

ASJC Scopus subject areas

  • Virology
  • Clinical Neurology

Cite this

Daily, A., Nath, A., & Hersh, L. B. (2006). Tat peptides inhibit neprilysin. Journal of NeuroVirology, 12(3), 153-160. https://doi.org/10.1080/13550280600760677

Tat peptides inhibit neprilysin. / Daily, Abigail; Nath, Avindra; Hersh, Louis B.

In: Journal of NeuroVirology, Vol. 12, No. 3, 06.2006, p. 153-160.

Research output: Contribution to journalArticle

Daily, A, Nath, A & Hersh, LB 2006, 'Tat peptides inhibit neprilysin', Journal of NeuroVirology, vol. 12, no. 3, pp. 153-160. https://doi.org/10.1080/13550280600760677
Daily, Abigail ; Nath, Avindra ; Hersh, Louis B. / Tat peptides inhibit neprilysin. In: Journal of NeuroVirology. 2006 ; Vol. 12, No. 3. pp. 153-160.
@article{3341da13ca474ae098dc7ce69fed8659,
title = "Tat peptides inhibit neprilysin",
abstract = "Dementia associated with human immunodeficiency virus (HIV) infection occurs commonly in the aging population and amyloid depositions are noted in the brains of patients with HIV infection in younger age groups. This suggests a dysregulation of amyloid processing in the setting of HIV infection. The Tat protein of HIV has been implicated in the neuropathogenesis of HIV infection due to its neurotoxic and glial activation properties. However, Tat protein and Tat-derived peptides were recently also shown to inhibit neprilysin, the major amyloid β peptide degrading enzyme in brain, in a cell aggregate system. This effect could contribute to the observed accumulation of amyloid in the brain of HIV-infected patients. The authors report here that peptides derived from the Tat protein, but not Tat protein itself, inhibit homogeneous recombinant neprilysin. This inhibition was found to be competitive and reversible and therefore does not involve covalent bond formation. Tat peptides and Tat protein were slowly hydrolyzed by neprilysin. Thus the accumulation of Tat-derived proteolytic fragments may serve to inhibit neprilysin and increase amyloid β peptide levels.",
keywords = "Amyloid β peptide, Catabolism, Inhibition, Neprilysin, Tat-derived peptides",
author = "Abigail Daily and Avindra Nath and Hersh, {Louis B.}",
year = "2006",
month = "6",
doi = "10.1080/13550280600760677",
language = "English (US)",
volume = "12",
pages = "153--160",
journal = "Journal of NeuroVirology",
issn = "1355-0284",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Tat peptides inhibit neprilysin

AU - Daily, Abigail

AU - Nath, Avindra

AU - Hersh, Louis B.

PY - 2006/6

Y1 - 2006/6

N2 - Dementia associated with human immunodeficiency virus (HIV) infection occurs commonly in the aging population and amyloid depositions are noted in the brains of patients with HIV infection in younger age groups. This suggests a dysregulation of amyloid processing in the setting of HIV infection. The Tat protein of HIV has been implicated in the neuropathogenesis of HIV infection due to its neurotoxic and glial activation properties. However, Tat protein and Tat-derived peptides were recently also shown to inhibit neprilysin, the major amyloid β peptide degrading enzyme in brain, in a cell aggregate system. This effect could contribute to the observed accumulation of amyloid in the brain of HIV-infected patients. The authors report here that peptides derived from the Tat protein, but not Tat protein itself, inhibit homogeneous recombinant neprilysin. This inhibition was found to be competitive and reversible and therefore does not involve covalent bond formation. Tat peptides and Tat protein were slowly hydrolyzed by neprilysin. Thus the accumulation of Tat-derived proteolytic fragments may serve to inhibit neprilysin and increase amyloid β peptide levels.

AB - Dementia associated with human immunodeficiency virus (HIV) infection occurs commonly in the aging population and amyloid depositions are noted in the brains of patients with HIV infection in younger age groups. This suggests a dysregulation of amyloid processing in the setting of HIV infection. The Tat protein of HIV has been implicated in the neuropathogenesis of HIV infection due to its neurotoxic and glial activation properties. However, Tat protein and Tat-derived peptides were recently also shown to inhibit neprilysin, the major amyloid β peptide degrading enzyme in brain, in a cell aggregate system. This effect could contribute to the observed accumulation of amyloid in the brain of HIV-infected patients. The authors report here that peptides derived from the Tat protein, but not Tat protein itself, inhibit homogeneous recombinant neprilysin. This inhibition was found to be competitive and reversible and therefore does not involve covalent bond formation. Tat peptides and Tat protein were slowly hydrolyzed by neprilysin. Thus the accumulation of Tat-derived proteolytic fragments may serve to inhibit neprilysin and increase amyloid β peptide levels.

KW - Amyloid β peptide

KW - Catabolism

KW - Inhibition

KW - Neprilysin

KW - Tat-derived peptides

UR - http://www.scopus.com/inward/record.url?scp=33750079287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750079287&partnerID=8YFLogxK

U2 - 10.1080/13550280600760677

DO - 10.1080/13550280600760677

M3 - Article

C2 - 16877296

AN - SCOPUS:33750079287

VL - 12

SP - 153

EP - 160

JO - Journal of NeuroVirology

JF - Journal of NeuroVirology

SN - 1355-0284

IS - 3

ER -